Vimarsana
Biggest News Aggregation in the World

Page 24 - Biocon Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biocon Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biocon Ltd Today - Breaking & Trending Today

Indices: Stock market update: Nifty Pharma index advances 1.03% - Vimarsana News

Indices: Stock market update: Nifty Pharma index advances 1.03%

The Nifty Pharma index closed 1.03 per cent up at 16562.6.

Biocon Biologics: Biocon Biologics inks pact with Sandoz to market product in Japan - Vimarsana News

Biocon Biologics: Biocon Biologics inks pact with Sandoz to market product in Japan

Adalimumab BS for subcutaneous injection is indicated for immune-related diseases such as rheumatoid arthritis, psoriasis vulgaris, ankylosing spondylitis, Crohn's disease, and ulcerative colitis.

Biocon Biologics, Sandoz sign pact to distribute adalimumab biosimilar Humira in Japan - Vimarsana News

Biocon Biologics, Sandoz sign pact to distribute adalimumab biosimilar Humira in Japan

Adalimumab BS for subcutaneous injection is a biosimilar of Humira, offering therapeutic solutions for immune-related diseases such as rheumatoid arthritis, psoriasis vulgaris, ankylosing spondylitis, Crohn's disease and ulcerative colitis

Biocon Biologics Partners with Sandoz for the Distribution of "Adalimumab BS Subcutaneous Injection [FKB]" in Japan – India Education | Latest Education News | Global Educational News - Vimarsana News

Biocon Biologics Partners with Sandoz for the Distribution of "Adalimumab BS Subcutaneous Injection [FKB]" in Japan – India Education | Latest Education News | Global Educational News

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), signed today a Distribution Agreement with Sandoz,  granting the Company the exclusive rights to promote, sell and

Indices: Stock market update: Nifty Pharma index falls 0.75% in a weak market - Vimarsana News

Indices: Stock market update: Nifty Pharma index falls 0.75% in a weak market

The Nifty Pharma index was trading 0.75 per cent down at 16000.05.